Literature DB >> 12390473

Endotoxin and its binding proteins in chronic liver disease: the effect of transjugular intrahepatic portosystemic shunting.

Arthur Kaser1, Othmar Ludwiczek, Peter Waldenberger, Werner Jaschke, Wolfgang Vogel, Herbert Tilg.   

Abstract

BACKGROUND: Gut-derived endotoxin is insufficiently cleared by the diseased liver, and thus, is elevated in plasma of patients with chronic liver disease (CLD). Endotoxin action might be modified by binding to soluble CD14 (sCD14) and lipopolysaccharide-binding protein (LBP), both of which have not yet been sufficiently studied in CLD.
METHODS: Endotoxin, sCD14 and LBP have been determined in peripheral blood of 72 patients and 39 control subjects, and in portal and hepatic venous blood of 12 patients during transjugular intrahepatic portosystemic shunt (TIPS) implantation.
RESULTS: Peripheral endotoxin (average 3-fold increased compared to controls), LBP, and sCD14 plasma levels were elevated in chronic liver disease irrespective of Child stage m, preserve/absence of cirrhosis or aetiology. LBP, and sCD14. Furthermore, endotoxin levels in the portal vein (38.1 +/- 6.1 pg/ml) were only slightly elevated compared to the hepatic vein (29.2 +/- 4.4 pg/ml), and peripheral endotoxin levels did not increase after TIPS.
CONCLUSIONS: Decreased hepatocellular function rather than hepatic blood shunting might be responsible for endotoxemia. The elevation in LBP and sCD14 levels may be a consequence of endotoxemia.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12390473     DOI: 10.1034/j.1600-0676.2002.01666.x

Source DB:  PubMed          Journal:  Liver        ISSN: 0106-9543


  8 in total

Review 1.  Markers of bacterial translocation in end-stage liver disease.

Authors:  Ioannis Koutsounas; Garyfallia Kaltsa; Spyros I Siakavellas; Giorgos Bamias
Journal:  World J Hepatol       Date:  2015-09-18

2.  Toll-like receptor 2-mediated intestinal injury and enteric tumor necrosis factor receptor I contribute to liver fibrosis in mice.

Authors:  Phillipp Hartmann; Michael Haimerl; Magdalena Mazagova; David A Brenner; Bernd Schnabl
Journal:  Gastroenterology       Date:  2012-07-27       Impact factor: 22.682

3.  Nutrition intervention: a strategy against systemic inflammatory syndrome.

Authors:  Helieh S Oz; Theresa S Chen; Manuela Neuman
Journal:  JPEN J Parenter Enteral Nutr       Date:  2009-04-14       Impact factor: 4.016

Review 4.  Fatigue in liver disease: pathophysiology and clinical management.

Authors:  Mark G Swain
Journal:  Can J Gastroenterol       Date:  2006-03       Impact factor: 3.522

Review 5.  Innate immune dysfunction in acute and chronic liver disease.

Authors:  Bettina Leber; Ursula Mayrhauser; Michael Rybczynski; Vanessa Stadlbauer
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

6.  Endotoxin and CD14 in the progression of biliary atresia.

Authors:  Ming-Huei Chou; Jiin-Haur Chuang; Hock-Liew Eng; Ching-Mei Chen; Chiou-Huey Wang; Chao-Long Chen; Tsun-Mei Lin
Journal:  J Transl Med       Date:  2010-12-21       Impact factor: 5.531

7.  Attenuation of congenital portosystemic shunt reduces inflammation in dogs.

Authors:  Michael S Tivers; Ian Handel; Adam G Gow; Victoria J Lipscomb; Rajiv Jalan; Richard J Mellanby
Journal:  PLoS One       Date:  2015-02-06       Impact factor: 3.240

8.  Direct Biomarkers of Microbial Translocation Correlate with Immune Activation in Adult Zambians with Environmental Enteropathy and Hepatosplenic Schistosomiasis.

Authors:  Patrick Kaonga; Evans Kaimoyo; Ellen Besa; Kanekwa Zyambo; Edford Sinkala; Paul Kelly
Journal:  Am J Trop Med Hyg       Date:  2017-11       Impact factor: 2.345

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.